Skip to main
IEX
IEX logo

IDEX (IEX) Stock Forecast & Price Target

IDEX (IEX) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 50%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

IDEX has generated $3.3 billion in revenue for 2024, showcasing a robust financial performance within its diversified business segments. The company possesses a well-established portfolio of highly-engineered solutions that are expected to grow at rates exceeding underlying GDP over economic cycles, supported by pricing power. Despite mixed end market conditions, including strengths in various sectors such as pharmaceuticals and stable OEM demand, IDEX’s strategic position underscores its potential for sustained growth.

Bears say

IDEX's financial outlook appears negative due to ongoing mixed organic sales and order trends across its three business segments, prompting a reduction in the core revenue growth forecast for 2026. Furthermore, while balance sheet net leverage showed a slight sequential decrease from 1.5x to 1.4x, the company anticipates flat to low single-digit declines in volume this year, which could compress earnings per share (EPS). Additionally, IDEX's gross debt/EBITDA ratio stands at 2.1x, reflecting a continued need for careful management of leverage amid challenging market conditions.

IDEX (IEX) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 50% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IDEX (IEX) Forecast

Analysts have given IDEX (IEX) a Buy based on their latest research and market trends.

According to 6 analysts, IDEX (IEX) has a Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $206.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $206.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IDEX (IEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.